GrippeAllemagneV3, Main, Exploration, bibRecord, 000386

Seroprevalence of influenza A and B in German infants and adolescents.

Identifieur interne : 000386 ( Main/Exploration ); précédent : 000385; suivant : 000387

Seroprevalence of influenza A and B in German infants and adolescents.

Auteurs : Andreas Sauerbrei [Allemagne] ; R. Schmidt-Ott ; H. Hoyer ; P. Wutzler

Source :

Medical microbiology and immunology [ 1432-1831 ] ; 2009.

RBID : pubmed:19194722

Descripteurs français

KwdFr :
- Adolescent, Adulte, Allemagne (épidémiologie), Anticorps antiviraux (sang), Enfant, Enfant d'âge préscolaire, Femelle, Grippe humaine (immunologie), Grippe humaine (sang), Grippe humaine (épidémiologie), Humains, Immunoglobuline G (sang), Jeune adulte, Mâle, Nourrisson, Prévalence, Virus de la grippe A (immunologie), Virus influenza B (immunologie), Études séroépidémiologiques.
MESH :
- immunologie : Grippe humaine, Virus de la grippe A, Virus influenza B.
- sang : Anticorps antiviraux, Grippe humaine, Immunoglobuline G.
- épidémiologie : Allemagne, Grippe humaine.
- Adolescent, Adulte, Enfant, Enfant d'âge préscolaire, Femelle, Humains, Jeune adulte, Mâle, Nourrisson, Prévalence, Études séroépidémiologiques.
Wicri :
- geographic : Allemagne.

English descriptors

KwdEn :
- Adolescent, Adult, Antibodies, Viral (blood), Child, Child, Preschool, Female, Germany (epidemiology), Humans, Immunoglobulin G (blood), Infant, Influenza A virus (immunology), Influenza B virus (immunology), Influenza, Human (blood), Influenza, Human (epidemiology), Influenza, Human (immunology), Male, Prevalence, Seroepidemiologic Studies, Young Adult.
MESH :
- chemical , blood : Antibodies, Viral, Immunoglobulin G.
- geographic , epidemiology : Germany.
- blood : Influenza, Human.
- epidemiology : Influenza, Human.
- immunology : Influenza A virus, Influenza B virus, Influenza, Human.
- Adolescent, Adult, Child, Child, Preschool, Female, Humans, Infant, Male, Prevalence, Seroepidemiologic Studies, Young Adult.

Abstract

The objective of this study was to provide seroepidemiological information on influenza A and B antibodies in children and adolescents. Viral immunoglobulin G antibodies were determined retrospectively using enzyme-linked immunosorbent assays in a group of 1,111 children and adolescents. Sera (809) from healthy adult blood donors served as controls. In children, the prevalence of antibodies against influenza A was 82.0% and against influenza B 9.6%, whereas in adults the prevalence of antibodies against influenza A was calculated as 99.4% and against influenza B 56.7%. After decline of maternal antibodies during the first year of life, there was an increase of prevalence of influenza A antibodies up to 100% by the age of 12 years. In contrast, only 1-2% of children up to 9 years had influenza B antibodies increasing to 25% by the age of 18 years and to 70% among adults aged 30 years. Children aged 0-6 years had significantly lower concentrations and >12-15-year-old adolescents had significantly higher concentrations of antibodies against influenza A than adults. For all age groups of children and adolescents, significantly lower antibody concentrations against influenza B were measured in comparison to the blood donor control group. In conclusion, the annual influenza vaccination in children and adolescents may improve considerably the protection against influenza virus infection occurring during epidemics.

DOI: 10.1007/s00430-009-0108-7
PubMed: 19194722

Affiliations:

Allemagne

Links toward previous steps (curation, corpus...)

to stream Main, to step Corpus: 000421
to stream Main, to step Curation: 000421

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Seroprevalence of influenza A and B in German infants and adolescents.</title>
<author><name sortKey="Sauerbrei, Andreas" sort="Sauerbrei, Andreas" uniqKey="Sauerbrei A" first="Andreas" last="Sauerbrei">Andreas Sauerbrei</name>
<affiliation wicri:level="1"><nlm:affiliation>Institute of Virology and Antiviral Therapy, Friedrich-Schiller University of Jena, Hans-Knoell-Strasse 2, 07745 Jena, Germany. Andreas.Sauerbrei@med.uni-jena.de</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Institute of Virology and Antiviral Therapy, Friedrich-Schiller University of Jena, Hans-Knoell-Strasse 2, 07745 Jena</wicri:regionArea>
<wicri:noRegion>07745 Jena</wicri:noRegion>
<wicri:noRegion>07745 Jena</wicri:noRegion>
<wicri:noRegion>07745 Jena</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Schmidt Ott, R" sort="Schmidt Ott, R" uniqKey="Schmidt Ott R" first="R" last="Schmidt-Ott">R. Schmidt-Ott</name>
</author>
<author><name sortKey="Hoyer, H" sort="Hoyer, H" uniqKey="Hoyer H" first="H" last="Hoyer">H. Hoyer</name>
</author>
<author><name sortKey="Wutzler, P" sort="Wutzler, P" uniqKey="Wutzler P" first="P" last="Wutzler">P. Wutzler</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2009">2009</date>
<idno type="RBID">pubmed:19194722</idno>
<idno type="pmid">19194722</idno>
<idno type="doi">10.1007/s00430-009-0108-7</idno>
<idno type="wicri:Area/Main/Corpus">000421</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000421</idno>
<idno type="wicri:Area/Main/Curation">000421</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000421</idno>
<idno type="wicri:Area/Main/Exploration">000421</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Seroprevalence of influenza A and B in German infants and adolescents.</title>
<author><name sortKey="Sauerbrei, Andreas" sort="Sauerbrei, Andreas" uniqKey="Sauerbrei A" first="Andreas" last="Sauerbrei">Andreas Sauerbrei</name>
<affiliation wicri:level="1"><nlm:affiliation>Institute of Virology and Antiviral Therapy, Friedrich-Schiller University of Jena, Hans-Knoell-Strasse 2, 07745 Jena, Germany. Andreas.Sauerbrei@med.uni-jena.de</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Institute of Virology and Antiviral Therapy, Friedrich-Schiller University of Jena, Hans-Knoell-Strasse 2, 07745 Jena</wicri:regionArea>
<wicri:noRegion>07745 Jena</wicri:noRegion>
<wicri:noRegion>07745 Jena</wicri:noRegion>
<wicri:noRegion>07745 Jena</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Schmidt Ott, R" sort="Schmidt Ott, R" uniqKey="Schmidt Ott R" first="R" last="Schmidt-Ott">R. Schmidt-Ott</name>
</author>
<author><name sortKey="Hoyer, H" sort="Hoyer, H" uniqKey="Hoyer H" first="H" last="Hoyer">H. Hoyer</name>
</author>
<author><name sortKey="Wutzler, P" sort="Wutzler, P" uniqKey="Wutzler P" first="P" last="Wutzler">P. Wutzler</name>
</author>
</analytic>
<series><title level="j">Medical microbiology and immunology</title>
<idno type="eISSN">1432-1831</idno>
<imprint><date when="2009" type="published">2009</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent</term>
<term>Adult</term>
<term>Antibodies, Viral (blood)</term>
<term>Child</term>
<term>Child, Preschool</term>
<term>Female</term>
<term>Germany (epidemiology)</term>
<term>Humans</term>
<term>Immunoglobulin G (blood)</term>
<term>Infant</term>
<term>Influenza A virus (immunology)</term>
<term>Influenza B virus (immunology)</term>
<term>Influenza, Human (blood)</term>
<term>Influenza, Human (epidemiology)</term>
<term>Influenza, Human (immunology)</term>
<term>Male</term>
<term>Prevalence</term>
<term>Seroepidemiologic Studies</term>
<term>Young Adult</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Adolescent</term>
<term>Adulte</term>
<term>Allemagne (épidémiologie)</term>
<term>Anticorps antiviraux (sang)</term>
<term>Enfant</term>
<term>Enfant d'âge préscolaire</term>
<term>Femelle</term>
<term>Grippe humaine (immunologie)</term>
<term>Grippe humaine (sang)</term>
<term>Grippe humaine (épidémiologie)</term>
<term>Humains</term>
<term>Immunoglobuline G (sang)</term>
<term>Jeune adulte</term>
<term>Mâle</term>
<term>Nourrisson</term>
<term>Prévalence</term>
<term>Virus de la grippe A (immunologie)</term>
<term>Virus influenza B (immunologie)</term>
<term>Études séroépidémiologiques</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en"><term>Antibodies, Viral</term>
<term>Immunoglobulin G</term>
</keywords>
<keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>Germany</term>
</keywords>
<keywords scheme="MESH" qualifier="blood" xml:lang="en"><term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Grippe humaine</term>
<term>Virus de la grippe A</term>
<term>Virus influenza B</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Influenza A virus</term>
<term>Influenza B virus</term>
<term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="sang" xml:lang="fr"><term>Anticorps antiviraux</term>
<term>Grippe humaine</term>
<term>Immunoglobuline G</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Allemagne</term>
<term>Grippe humaine</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adolescent</term>
<term>Adult</term>
<term>Child</term>
<term>Child, Preschool</term>
<term>Female</term>
<term>Humans</term>
<term>Infant</term>
<term>Male</term>
<term>Prevalence</term>
<term>Seroepidemiologic Studies</term>
<term>Young Adult</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Adolescent</term>
<term>Adulte</term>
<term>Enfant</term>
<term>Enfant d'âge préscolaire</term>
<term>Femelle</term>
<term>Humains</term>
<term>Jeune adulte</term>
<term>Mâle</term>
<term>Nourrisson</term>
<term>Prévalence</term>
<term>Études séroépidémiologiques</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Allemagne</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">The objective of this study was to provide seroepidemiological information on influenza A and B antibodies in children and adolescents. Viral immunoglobulin G antibodies were determined retrospectively using enzyme-linked immunosorbent assays in a group of 1,111 children and adolescents. Sera (809) from healthy adult blood donors served as controls. In children, the prevalence of antibodies against influenza A was 82.0% and against influenza B 9.6%, whereas in adults the prevalence of antibodies against influenza A was calculated as 99.4% and against influenza B 56.7%. After decline of maternal antibodies during the first year of life, there was an increase of prevalence of influenza A antibodies up to 100% by the age of 12 years. In contrast, only 1-2% of children up to 9 years had influenza B antibodies increasing to 25% by the age of 18 years and to 70% among adults aged 30 years. Children aged 0-6 years had significantly lower concentrations and >12-15-year-old adolescents had significantly higher concentrations of antibodies against influenza A than adults. For all age groups of children and adolescents, significantly lower antibody concentrations against influenza B were measured in comparison to the blood donor control group. In conclusion, the annual influenza vaccination in children and adolescents may improve considerably the protection against influenza virus infection occurring during epidemics.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">19194722</PMID>
<DateCompleted><Year>2009</Year>
<Month>05</Month>
<Day>06</Day>
</DateCompleted>
<DateRevised><Year>2018</Year>
<Month>11</Month>
<Day>13</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-1831</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>198</Volume>
<Issue>2</Issue>
<PubDate><Year>2009</Year>
<Month>May</Month>
</PubDate>
</JournalIssue>
<Title>Medical microbiology and immunology</Title>
<ISOAbbreviation>Med. Microbiol. Immunol.</ISOAbbreviation>
</Journal>
<ArticleTitle>Seroprevalence of influenza A and B in German infants and adolescents.</ArticleTitle>
<Pagination><MedlinePgn>93-101</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1007/s00430-009-0108-7</ELocationID>
<Abstract><AbstractText>The objective of this study was to provide seroepidemiological information on influenza A and B antibodies in children and adolescents. Viral immunoglobulin G antibodies were determined retrospectively using enzyme-linked immunosorbent assays in a group of 1,111 children and adolescents. Sera (809) from healthy adult blood donors served as controls. In children, the prevalence of antibodies against influenza A was 82.0% and against influenza B 9.6%, whereas in adults the prevalence of antibodies against influenza A was calculated as 99.4% and against influenza B 56.7%. After decline of maternal antibodies during the first year of life, there was an increase of prevalence of influenza A antibodies up to 100% by the age of 12 years. In contrast, only 1-2% of children up to 9 years had influenza B antibodies increasing to 25% by the age of 18 years and to 70% among adults aged 30 years. Children aged 0-6 years had significantly lower concentrations and >12-15-year-old adolescents had significantly higher concentrations of antibodies against influenza A than adults. For all age groups of children and adolescents, significantly lower antibody concentrations against influenza B were measured in comparison to the blood donor control group. In conclusion, the annual influenza vaccination in children and adolescents may improve considerably the protection against influenza virus infection occurring during epidemics.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sauerbrei</LastName>
<ForeName>Andreas</ForeName>
<Initials>A</Initials>
<AffiliationInfo><Affiliation>Institute of Virology and Antiviral Therapy, Friedrich-Schiller University of Jena, Hans-Knoell-Strasse 2, 07745 Jena, Germany. Andreas.Sauerbrei@med.uni-jena.de</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Schmidt-Ott</LastName>
<ForeName>R</ForeName>
<Initials>R</Initials>
</Author>
<Author ValidYN="Y"><LastName>Hoyer</LastName>
<ForeName>H</ForeName>
<Initials>H</Initials>
</Author>
<Author ValidYN="Y"><LastName>Wutzler</LastName>
<ForeName>P</ForeName>
<Initials>P</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2009</Year>
<Month>02</Month>
<Day>05</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>Germany</Country>
<MedlineTA>Med Microbiol Immunol</MedlineTA>
<NlmUniqueID>0314524</NlmUniqueID>
<ISSNLinking>0300-8584</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D007074">Immunoglobulin G</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName>
<QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005858" MajorTopicYN="N" Type="Geographic">Germany</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007074" MajorTopicYN="N">Immunoglobulin G</DescriptorName>
<QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D009980" MajorTopicYN="N">Influenza A virus</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D009981" MajorTopicYN="N">Influenza B virus</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName>
<QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
<QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016036" MajorTopicYN="N">Seroepidemiologic Studies</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2008</Year>
<Month>11</Month>
<Day>20</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2009</Year>
<Month>2</Month>
<Day>6</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2009</Year>
<Month>2</Month>
<Day>6</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2009</Year>
<Month>5</Month>
<Day>7</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">19194722</ArticleId>
<ArticleId IdType="doi">10.1007/s00430-009-0108-7</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>J Infect Dis. 2000 Oct;182(4):1218-21</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10979921</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2000 Jan 27;342(4):232-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10648764</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Pediatrics. 1988 Jul;82(1):83-90</Citation>
<ArticleIdList><ArticleId IdType="pubmed">3380603</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Br J Exp Pathol. 1977 Aug;58(4):378-85</Citation>
<ArticleIdList><ArticleId IdType="pubmed">911668</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>MMWR Recomm Rep. 2007 Jul 13;56(RR-6):1-54</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17625497</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Med Microbiol Immunol. 2006 Jun;195(2):45-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16411135</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Pediatrics. 2002 Dec;110(6):1246-52</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12456926</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Epidemiol Infect. 2002 Dec;129(3):525-33</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12558335</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Paediatr Respir Rev. 2003 Jun;4(2):99-104</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12758046</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Med Klin (Munich). 2005 Jan 15;100(1):6-13</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15654537</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Eur J Pediatr. 2006 Apr;165(4):223-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16369798</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Infect Dis. 1981 Nov;144(5):433-41</Citation>
<ArticleIdList><ArticleId IdType="pubmed">6273473</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 1999 May 6;340(18):1377-82</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10228187</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>MMWR Recomm Rep. 2006 Jul 28;55(RR-10):1-42</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16874296</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2000 Jan 27;342(4):225-31</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10648763</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Infect Dis. 1979 Oct;140(4):610-3</Citation>
<ArticleIdList><ArticleId IdType="pubmed">512419</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Eur J Pediatr. 2007 Jun;166(6):629-31</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17008996</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Pediatr. 2000 Dec;137(6):856-64</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11113844</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Vaccine. 2007 Dec 21;26(1):32-40</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18022736</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Clin Virol. 2008 May;42(1):45-51</Citation>
<ArticleIdList><ArticleId IdType="pubmed">18325832</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Pediatrics. 2001 Oct;108(4):E63</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11581471</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Infect Dis. 2004 Oct 15;39(8):1223-30</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15486848</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Med Microbiol Immunol. 2002 Dec;191(3-4):157-60</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12458351</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Infect Dis. 1987 Jun;155(6):1119-26</Citation>
<ArticleIdList><ArticleId IdType="pubmed">3572033</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Pediatr Infect Dis J. 1997 Nov;16(11):1065-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9384341</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 1978 Mar 16;298(11):587-92</Citation>
<ArticleIdList><ArticleId IdType="pubmed">628375</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Can Commun Dis Rep. 2006 Jun 15;32(ACS-7):1-27</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16805064</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2003 Oct;77(19):10630-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12970447</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Pediatr Infect Dis J. 1989 Feb;8(2):94-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">2495520</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Med Microbiol Immunol. 2007 Dec;196(4):181-90</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17492465</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Infect Dis. 2004 Oct 15;190(8):1369-73</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15378427</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Emerg Infect Dis. 2007 Mar;13(3):426-35</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17552096</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 1983 Sep;47(3):642-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">6688639</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Infect Dis. 2006 Jul 15;43(2):132-40</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16779738</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Med Microbiol Immunol. 2007 Dec;196(4):213-25</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17541633</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Infect Dis. 2003 Feb 1;36(3):299-305</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12539071</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Infect Dis. 2002 Jan 15;185(2):147-52</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11807687</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Epidemiol Infect. 1993 Feb;110(1):145-60</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8432318</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Berl Munch Tierarztl Wochenschr. 2006 Mar-Apr;119(3-4):167-78</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16573207</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Pediatrics. 2003 Sep;112(3 Pt 1):e197-201</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12949312</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Int J Infect Dis. 2007 Jan;11(1):40-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16678464</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>JAMA. 2003 Jan 8;289(2):179-86</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12517228</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 1977 Apr 14;296(15):829-34</Citation>
<ArticleIdList><ArticleId IdType="pubmed">846492</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Pediatrics. 2004 Nov;114(5):e626-33</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15520093</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Pediatr Infect Dis J. 1987 Apr;6(4):398-403</Citation>
<ArticleIdList><ArticleId IdType="pubmed">3588113</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Arch Dis Child. 2004 Nov;89(11):1002-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15499051</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>Allemagne</li>
</country>
</list>
<tree><noCountry><name sortKey="Hoyer, H" sort="Hoyer, H" uniqKey="Hoyer H" first="H" last="Hoyer">H. Hoyer</name>
<name sortKey="Schmidt Ott, R" sort="Schmidt Ott, R" uniqKey="Schmidt Ott R" first="R" last="Schmidt-Ott">R. Schmidt-Ott</name>
<name sortKey="Wutzler, P" sort="Wutzler, P" uniqKey="Wutzler P" first="P" last="Wutzler">P. Wutzler</name>
</noCountry>
<country name="Allemagne"><noRegion><name sortKey="Sauerbrei, Andreas" sort="Sauerbrei, Andreas" uniqKey="Sauerbrei A" first="Andreas" last="Sauerbrei">Andreas Sauerbrei</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/GrippeAllemagneV3/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000386 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000386 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    GrippeAllemagneV3
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:19194722
   |texte=   Seroprevalence of influenza A and B in German infants and adolescents.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:19194722" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a GrippeAllemagneV3

This area was generated with Dilib version V0.6.35.
Data generation: Tue Jul 7 11:47:10 2020. Site generation: Sat Sep 26 09:55:33 2020

	Corpus GrippeAllemagneV3
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Corpus GrippeAllemagneV3

Seroprevalence of influenza A and B in German infants and adolescents.

Seroprevalence of influenza A and B in German infants and adolescents.

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki